首页 > 最新文献

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy最新文献

英文 中文
Risk factors associated with mortality among patients on maintenance hemodialysis: The Thailand Renal Replacement Therapy registry. 与维持性血液透析患者死亡率相关的风险因素:泰国肾脏替代疗法登记。
Artchawin Premprasong, Naowanit Nata, Theerasak Tangwonglert, Ouppatham Supasyndh, Bancha Satirapoj

Introduction: End-stage kidney disease (ESKD) has been increasing in prevalence across the world, including Thailand, and patients with ESKD on hemodialysis have a high mortality risk.

Methods: A retrospective cohort study was performed across 855 hemodialysis centers in the Thailand Renal Replacement Therapy registry. The database and mortality data were analyzed.

Results: A total of 58 952 patients were included. The survival rates at 1, 3, and 5 years were 93.5%, 69.7%, and 41.2%, respectively. On multivariate analysis, factors such as aging, permanent catheter or arteriovenous graft, twice-weekly hemodialysis, low levels of urea reduction ratio, normalized protein catabolic rate, hemoglobin, transferrin saturation, serum albumin, LDL-cholesterol, intact-parathyroid hormone, uric acid, sodium, phosphate, and bicarbonate were significantly related to death.

Conclusion: Mortality is high in ESKD patients on hemodialysis. Age, type of vascular access, twice-weekly hemodialysis, inadequate dialysis, low protein intake, anemia, abnormal electrolytes, and bone mineral disorders are associated with all-cause mortality.

简介:末期肾病(ESKD)在包括泰国在内的世界各地发病率不断上升,接受血液透析的末期肾病患者死亡率很高:包括泰国在内的全球范围内,终末期肾病(ESKD)的发病率不断上升,接受血液透析的终末期肾病患者的死亡率很高:泰国肾脏替代疗法登记处对 855 个血液透析中心进行了回顾性队列研究。分析了数据库和死亡率数据:结果:共纳入 58 952 名患者。1年、3年和5年的存活率分别为93.5%、69.7%和41.2%。多变量分析显示,年龄、永久导管或动静脉移植、每周两次血液透析、低水平尿素还原比、正常化蛋白分解率、血红蛋白、转铁蛋白饱和度、血清白蛋白、低密度脂蛋白胆固醇、完整甲状旁腺激素、尿酸、钠、磷酸盐和碳酸氢盐等因素与死亡显著相关:结论:接受血液透析的 ESKD 患者死亡率很高。年龄、血管通路类型、每周两次血液透析、透析不足、蛋白质摄入量低、贫血、电解质异常和骨矿物质紊乱与全因死亡率有关。
{"title":"Risk factors associated with mortality among patients on maintenance hemodialysis: The Thailand Renal Replacement Therapy registry.","authors":"Artchawin Premprasong, Naowanit Nata, Theerasak Tangwonglert, Ouppatham Supasyndh, Bancha Satirapoj","doi":"10.1111/1744-9987.14166","DOIUrl":"10.1111/1744-9987.14166","url":null,"abstract":"<p><strong>Introduction: </strong>End-stage kidney disease (ESKD) has been increasing in prevalence across the world, including Thailand, and patients with ESKD on hemodialysis have a high mortality risk.</p><p><strong>Methods: </strong>A retrospective cohort study was performed across 855 hemodialysis centers in the Thailand Renal Replacement Therapy registry. The database and mortality data were analyzed.</p><p><strong>Results: </strong>A total of 58 952 patients were included. The survival rates at 1, 3, and 5 years were 93.5%, 69.7%, and 41.2%, respectively. On multivariate analysis, factors such as aging, permanent catheter or arteriovenous graft, twice-weekly hemodialysis, low levels of urea reduction ratio, normalized protein catabolic rate, hemoglobin, transferrin saturation, serum albumin, LDL-cholesterol, intact-parathyroid hormone, uric acid, sodium, phosphate, and bicarbonate were significantly related to death.</p><p><strong>Conclusion: </strong>Mortality is high in ESKD patients on hemodialysis. Age, type of vascular access, twice-weekly hemodialysis, inadequate dialysis, low protein intake, anemia, abnormal electrolytes, and bone mineral disorders are associated with all-cause mortality.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"839-854"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of vascular endothelial growth factor-C, plasma angiotensinogen and left ventricular hypertrophy in patients with hemodialysis. 血液透析患者的血管内皮生长因子-C、血浆血管紧张素原与左心室肥厚的关系。
Haci Hasan Yeter, Mustafa Levent, Levent Sahiner, Tolga Yildirim, Rahmi Yilmaz

Introduction: This study aims to examine the relationship between fluid overload, Vascular Endothelial Growth Factor C (VEGF-C), plasma Angiotensinogen (pAGT), and echocardiography findings in hemodialysis patients.

Methods: This was a single-center, cross-sectional study. Patients were divided into two groups according to mid-week inter-dialytic weight gain (mIDWG): (1) mIDWG ≤3% and (2) mIDW >3%.

Results: A total of 55 patients were enrolled in this study. While the mean pAGT and left ventricular mass index were significantly higher in patients with mIDWG >3% compared to patients with mIDWG ≤3%, VEGF-C was similar between groups. pAGT ≥76.8 mcg/L, VEGF-C ≤175.5 pg/ML, and pAGT /VEGF-C ≥0.45 were significant cut-offs for the prediction of left ventricular hypertrophy(LVH). Univariate logistic regression analysis revealed that these cut-off values were significantly associated with LVH.

Conclusion: Renin-angiotensin-aldosterone system activation may persist in hemodialysis patients with excessive IDWG. Additionally, pAGT and VEGF-C could be risk factors for the development of LVH.

简介本研究旨在探讨血液透析患者液体超负荷、血管内皮生长因子 C(VEGF-C)、血浆血管紧张素原(pAGT)和超声心动图结果之间的关系:这是一项单中心横断面研究。方法:这是一项单中心横断面研究,根据周中透析间体重增加(mIDWG)情况将患者分为两组:(1)mIDWG ≤3%;(2)mIDW >3%:本研究共纳入 55 名患者。pAGT≥76.8 mcg/L、VEGF-C≤175.5 pg/ML、pAGT /VEGF-C≥0.45是预测左心室肥厚(LVH)的重要临界值。单变量逻辑回归分析表明,这些临界值与左心室肥厚显著相关:结论:肾素-血管紧张素-醛固酮系统激活可能会持续存在于IDWG过高的血液透析患者中。结论:IDWG 过高的血液透析患者的肾素-血管紧张素-醛固酮系统激活可能持续存在,此外,pAGT 和 VEGF-C 可能是导致左心室积水的危险因素。
{"title":"Association of vascular endothelial growth factor-C, plasma angiotensinogen and left ventricular hypertrophy in patients with hemodialysis.","authors":"Haci Hasan Yeter, Mustafa Levent, Levent Sahiner, Tolga Yildirim, Rahmi Yilmaz","doi":"10.1111/1744-9987.14178","DOIUrl":"10.1111/1744-9987.14178","url":null,"abstract":"<p><strong>Introduction: </strong>This study aims to examine the relationship between fluid overload, Vascular Endothelial Growth Factor C (VEGF-C), plasma Angiotensinogen (pAGT), and echocardiography findings in hemodialysis patients.</p><p><strong>Methods: </strong>This was a single-center, cross-sectional study. Patients were divided into two groups according to mid-week inter-dialytic weight gain (mIDWG): (1) mIDWG ≤3% and (2) mIDW >3%.</p><p><strong>Results: </strong>A total of 55 patients were enrolled in this study. While the mean pAGT and left ventricular mass index were significantly higher in patients with mIDWG >3% compared to patients with mIDWG ≤3%, VEGF-C was similar between groups. pAGT ≥76.8 mcg/L, VEGF-C ≤175.5 pg/ML, and pAGT /VEGF-C ≥0.45 were significant cut-offs for the prediction of left ventricular hypertrophy(LVH). Univariate logistic regression analysis revealed that these cut-off values were significantly associated with LVH.</p><p><strong>Conclusion: </strong>Renin-angiotensin-aldosterone system activation may persist in hemodialysis patients with excessive IDWG. Additionally, pAGT and VEGF-C could be risk factors for the development of LVH.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"904-911"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141422375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk assessment for hypocalcemia in therapeutic apheresis for kidney transplantation. 肾移植治疗性血液透析中的低钙血症风险评估。
Chimezie Godswill Okwuonu, Monarch Shah, Iram Rafique, Abdallah Saleh Abdelrazeq, Korshie Dumor, Rasheed A Balogun

Introduction: The increase in the number of kidney transplants performed in the United States has been paralleled with an increase in the utilization of therapeutic apheresis (TA) for kidney transplant indications. Hypocalcemia remains a significant contributor to the adverse event in TA. The magnitude of hypocalcemia and its risk factors are scarcely discussed in literature.

Methods: This is a retrospective cohort review of adults from 18 years and above who received TA for kidney transplant-related indications from January 1, 2017 to December 31, 2022. Data extracted included basic demographics, indication for apheresis, procedure characteristics, serum ionized calcium at the mid and end of procedure and serum creatinine at the beginning of apheresis, and so forth.

Results: Data from 131 patients and 860 sessions of TA were analyzed. Antibody-mediated rejection (69%) and recurrent FSGS (15%) were the leading indications for TA. There were 60 (7%) TA sessions complicated by hypocalcemia. Of these, 53 (88%) occurred in the first session, 5 (8%) occurred in second session while 2 (4%) occurred in the third and subsequent sessions. Female sex, elevated serum creatinine and use of fresh frozen plasma- are the risk factors for hypocalcemia with odd's ratio of 2.34, 7.42, and 5.01, respectively. Binary logistic regression showed that elevated serum creatinine at the commencement of therapy is an independent predictor of hypocalcemia (adjusted odd's ratio = 3.31, p = 0.001).

Conclusion: Hypocalcemia is prevalent in this study. Clinical vigilance and tailored procedure will avert adverse consequences.

导言:随着美国肾移植数量的增加,用于肾移植适应症的治疗性无细胞疗法(TA)的使用率也在增加。低钙血症仍然是导致治疗性无细胞疗法不良反应的一个重要因素。低钙血症的严重程度及其风险因素在文献中鲜有讨论:这是一项回顾性队列研究,研究对象为 2017 年 1 月 1 日至 2022 年 12 月 31 日期间因肾移植相关适应症接受 TA 的 18 岁及以上成人。提取的数据包括基本人口统计学特征、无瓣取血适应症、手术特征、手术中期和结束时的血清离子钙以及无瓣取血开始时的血清肌酐等:对131名患者和860次TA的数据进行了分析。抗体介导的排斥反应(69%)和复发性 FSGS(15%)是 TA 的主要适应症。有60次(7%)TA治疗并发低钙血症。其中,53例(88%)发生在第一次治疗中,5例(8%)发生在第二次治疗中,2例(4%)发生在第三次及以后的治疗中。女性性别、血清肌酐升高和使用新鲜冰冻血浆是低钙血症的风险因素,其奇偶比分别为 2.34、7.42 和 5.01。二元逻辑回归显示,开始治疗时血清肌酐升高是低钙血症的独立预测因素(调整后奇异比 = 3.31,P = 0.001):本研究中普遍存在低钙血症。结论:本研究中普遍存在低钙血症,临床警惕性和量身定制的程序将避免不良后果。
{"title":"Risk assessment for hypocalcemia in therapeutic apheresis for kidney transplantation.","authors":"Chimezie Godswill Okwuonu, Monarch Shah, Iram Rafique, Abdallah Saleh Abdelrazeq, Korshie Dumor, Rasheed A Balogun","doi":"10.1111/1744-9987.14168","DOIUrl":"10.1111/1744-9987.14168","url":null,"abstract":"<p><strong>Introduction: </strong>The increase in the number of kidney transplants performed in the United States has been paralleled with an increase in the utilization of therapeutic apheresis (TA) for kidney transplant indications. Hypocalcemia remains a significant contributor to the adverse event in TA. The magnitude of hypocalcemia and its risk factors are scarcely discussed in literature.</p><p><strong>Methods: </strong>This is a retrospective cohort review of adults from 18 years and above who received TA for kidney transplant-related indications from January 1, 2017 to December 31, 2022. Data extracted included basic demographics, indication for apheresis, procedure characteristics, serum ionized calcium at the mid and end of procedure and serum creatinine at the beginning of apheresis, and so forth.</p><p><strong>Results: </strong>Data from 131 patients and 860 sessions of TA were analyzed. Antibody-mediated rejection (69%) and recurrent FSGS (15%) were the leading indications for TA. There were 60 (7%) TA sessions complicated by hypocalcemia. Of these, 53 (88%) occurred in the first session, 5 (8%) occurred in second session while 2 (4%) occurred in the third and subsequent sessions. Female sex, elevated serum creatinine and use of fresh frozen plasma- are the risk factors for hypocalcemia with odd's ratio of 2.34, 7.42, and 5.01, respectively. Binary logistic regression showed that elevated serum creatinine at the commencement of therapy is an independent predictor of hypocalcemia (adjusted odd's ratio = 3.31, p = 0.001).</p><p><strong>Conclusion: </strong>Hypocalcemia is prevalent in this study. Clinical vigilance and tailored procedure will avert adverse consequences.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"855-862"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141201360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effective exosomes reduction in hypercholesterinemic patients suffering from cardiovascular diseases by lipoprotein apheresis: Exosomes apheresis. 通过脂蛋白清除术有效减少心血管疾病高胆固醇血症患者体内的外泌体:外泌体分离。
Sophie Schröder, Robert Epple, Andre Fischer, Volker J J Schettler

Introduction: Extracellular vesicles (EVs) have been identified as playing a role in atherosclerosis.

Methods: A group of 37 hypercholesterolemic patients with atherosclerotic cardiovascular diseases (ASCVD) and 9 patients requiring hemodialysis (HD) were selected for the study.

Results: EVs were comparably reduced by various LA methods (Thermo: 87.66% ± 3.64, DALI: 87.96% ± 4.81, H.E.L.P.: 83.38% ± 11.98; represented as SEM). However, LDL-C (66%; 55%; 75%) and Lp(a) (72%; 67%; 79%) were less effectively reduced by DALI. There was no significant difference in the reduction of EVs when comparing different techniques, such as hemoperfusion (DALI; n = 13), a precipitation (H.E.L.P.; n = 5), and a double filtration procedure (Thermofiltration; n = 19). Additionally, no effect of hemodialysis on EVs reduction was found.

Conclusions: The study suggests that EVs can be effectively removed by various LA procedures, and this effect appears to be independent of the specific LA procedure used, as compared to hemodialysis.

引言细胞外囊泡(EVs)已被确认在动脉粥样硬化中发挥作用:研究选择了37名患有动脉粥样硬化性心血管疾病(ASCVD)的高胆固醇血症患者和9名需要血液透析(HD)的患者:各种 LA 方法均可显著降低 EVs(Thermo:87.66% ± 3.64;DALI:87.96% ± 4.81;H.E.L.P. :83.38% ± 11.98;以 SEM 表示)。然而,DALI降低低密度脂蛋白胆固醇(66%;55%;75%)和脂蛋白(a)(72%;67%;79%)的效果较差。比较不同的技术,如血液灌流(DALI;n = 13)、沉淀(H.E.L.P.;n = 5)和双重过滤程序(Thermofiltration;n = 19),在减少 EVs 方面没有明显差异。此外,血液透析对减少 EVs 没有影响:该研究表明,与血液透析相比,各种LA程序都能有效清除EVs,而且这种效果似乎与所使用的特定LA程序无关。
{"title":"Effective exosomes reduction in hypercholesterinemic patients suffering from cardiovascular diseases by lipoprotein apheresis: Exosomes apheresis.","authors":"Sophie Schröder, Robert Epple, Andre Fischer, Volker J J Schettler","doi":"10.1111/1744-9987.14172","DOIUrl":"10.1111/1744-9987.14172","url":null,"abstract":"<p><strong>Introduction: </strong>Extracellular vesicles (EVs) have been identified as playing a role in atherosclerosis.</p><p><strong>Methods: </strong>A group of 37 hypercholesterolemic patients with atherosclerotic cardiovascular diseases (ASCVD) and 9 patients requiring hemodialysis (HD) were selected for the study.</p><p><strong>Results: </strong>EVs were comparably reduced by various LA methods (Thermo: 87.66% ± 3.64, DALI: 87.96% ± 4.81, H.E.L.P.: 83.38% ± 11.98; represented as SEM). However, LDL-C (66%; 55%; 75%) and Lp(a) (72%; 67%; 79%) were less effectively reduced by DALI. There was no significant difference in the reduction of EVs when comparing different techniques, such as hemoperfusion (DALI; n = 13), a precipitation (H.E.L.P.; n = 5), and a double filtration procedure (Thermofiltration; n = 19). Additionally, no effect of hemodialysis on EVs reduction was found.</p><p><strong>Conclusions: </strong>The study suggests that EVs can be effectively removed by various LA procedures, and this effect appears to be independent of the specific LA procedure used, as compared to hemodialysis.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"863-870"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141262092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of the perceptions of health-related quality of life in Greek patients undergoing automated peritoneal dialysis with remote monitoring: A qualitative study. 评估接受远程监控自动腹膜透析的希腊患者对健康相关生活质量的看法:定性研究。
Kyriakos Kiourtidis, Sofia Nikolaidou, Erasmia Rouka, Jacek Lange, Konstantina Griva, Vassilios Liakopoulos, Sotirios G Zarogiannis

Background: This study aimed to explore in depth the lived experience and quality of life outcomes in patients receiving automated peritoneal dialysis (APD) treatment.

Methods: The study adhered to the standards of the Consolidated Criteria for Reporting Qualitative Research. A total of 19 APD patients were recruited and assessed using in-depth semi-structured interviews on various aspects of life with respect to APD modality. The interviews were transcribed verbatim and analyzed using Interpretive Phenomenological Analysis.

Results: Study findings generated five superordinate themes: (a) treatment-free daily routine, (b) sleep disturbances, (c) remote care, (d) limitations of peritoneal dialysis, and (e) the dimension of chronic disease. Further analysis of the material revealed the relationship of these themes with individual patient characteristics.

Conclusions: Overall, our findings suggest that APD characteristics contribute to the perceptions of quality of life in patients under dialysis considerably.

背景本研究旨在深入探讨接受自动腹膜透析(APD)治疗的患者的生活体验和生活质量结果:本研究遵循《定性研究报告综合标准》的标准。研究共招募了 19 名自动腹膜透析患者,并通过深入的半结构式访谈对他们进行了评估,内容涉及自动腹膜透析模式下生活的各个方面。访谈内容逐字记录,并采用解释性现象学分析方法进行分析:研究结果产生了五个上位主题:(a) 无治疗的日常生活,(b) 睡眠障碍,(c) 远程护理,(d) 腹膜透析的局限性,以及 (e) 慢性病的维度。对材料的进一步分析表明了这些主题与患者个人特征之间的关系:总体而言,我们的研究结果表明,腹膜透析患者的特征在很大程度上影响了他们对生活质量的看法。
{"title":"Assessment of the perceptions of health-related quality of life in Greek patients undergoing automated peritoneal dialysis with remote monitoring: A qualitative study.","authors":"Kyriakos Kiourtidis, Sofia Nikolaidou, Erasmia Rouka, Jacek Lange, Konstantina Griva, Vassilios Liakopoulos, Sotirios G Zarogiannis","doi":"10.1111/1744-9987.14180","DOIUrl":"10.1111/1744-9987.14180","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to explore in depth the lived experience and quality of life outcomes in patients receiving automated peritoneal dialysis (APD) treatment.</p><p><strong>Methods: </strong>The study adhered to the standards of the Consolidated Criteria for Reporting Qualitative Research. A total of 19 APD patients were recruited and assessed using in-depth semi-structured interviews on various aspects of life with respect to APD modality. The interviews were transcribed verbatim and analyzed using Interpretive Phenomenological Analysis.</p><p><strong>Results: </strong>Study findings generated five superordinate themes: (a) treatment-free daily routine, (b) sleep disturbances, (c) remote care, (d) limitations of peritoneal dialysis, and (e) the dimension of chronic disease. Further analysis of the material revealed the relationship of these themes with individual patient characteristics.</p><p><strong>Conclusions: </strong>Overall, our findings suggest that APD characteristics contribute to the perceptions of quality of life in patients under dialysis considerably.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"923-930"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141461529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complications of therapeutic plasma exchange: A retrospective, single-center study of 2505 procedures performed in 338 patients over 15 years. 治疗性血浆置换并发症:15 年间对 338 名患者进行的 2505 次手术的单中心回顾性研究。
Ece Vural, Tuğrul Elverdi, Ayşe Salihoğlu, Muhlis Cem Ar, Şeniz Öngören, Zafer Başlar, Teoman Soysal, Ahmet Emre Eşkazan

Introduction: Therapeutic plasma exchange (TPE) may involve complications. We aimed to review the demographic data, indications, technical information, and complications.

Methods: Data for TPE procedures (TPEPs) performed between 2004 and 2018 were retrospectively.

Results: This study covered 2505 TPEPs performed on 338 patients; 55% of them were female (n = 186), and the median age was 36 years (range, 11-93 years). Most TPEPs were administered for hematological (40.6%) indications. The incidence of complications on the first procedure was 3.2% (n = 80); only 16 procedures (0.6%) were failed. The complication incidence was 19.8% (n = 497), with 789 total complications. Most of the complications were patient-related (90.4%), and the most of them were urticaria (29.1%), occlusion (3.2%), and faulty systems (1.01%), respectively. The use of only fresh frozen plasma as replacement fluid caused a higher complication rate (22.1%, p < 0.01).

Conclusion: The number of TPEPs is increasing every day. Hematologic indications for TPE and the use of fresh frozen plasma may increase the risk of complications.

简介治疗性血浆置换术(TPE)可能会出现并发症。我们旨在回顾人口统计学数据、适应症、技术信息和并发症:回顾性分析2004年至2018年间实施的治疗性血浆置换术(TPE)的数据:本研究涵盖了为 338 名患者实施的 2505 例 TPEP,其中 55% 为女性(n = 186),中位年龄为 36 岁(范围为 11-93 岁)。大多数 TPEP 是针对血液学适应症实施的(40.6%)。首次手术的并发症发生率为 3.2%(n = 80);只有 16 例手术(0.6%)失败。并发症发生率为 19.8%(n = 497),并发症总数为 789 例。大部分并发症与患者有关(90.4%),其中最多的分别是荨麻疹(29.1%)、闭塞(3.2%)和系统故障(1.01%)。仅使用新鲜冰冻血浆作为置换液会导致更高的并发症发生率(22.1%,P 结语):TPEP的数量与日俱增。TPE的血液学适应症和新鲜冰冻血浆的使用可能会增加并发症的风险。
{"title":"Complications of therapeutic plasma exchange: A retrospective, single-center study of 2505 procedures performed in 338 patients over 15 years.","authors":"Ece Vural, Tuğrul Elverdi, Ayşe Salihoğlu, Muhlis Cem Ar, Şeniz Öngören, Zafer Başlar, Teoman Soysal, Ahmet Emre Eşkazan","doi":"10.1111/1744-9987.14173","DOIUrl":"10.1111/1744-9987.14173","url":null,"abstract":"<p><strong>Introduction: </strong>Therapeutic plasma exchange (TPE) may involve complications. We aimed to review the demographic data, indications, technical information, and complications.</p><p><strong>Methods: </strong>Data for TPE procedures (TPEPs) performed between 2004 and 2018 were retrospectively.</p><p><strong>Results: </strong>This study covered 2505 TPEPs performed on 338 patients; 55% of them were female (n = 186), and the median age was 36 years (range, 11-93 years). Most TPEPs were administered for hematological (40.6%) indications. The incidence of complications on the first procedure was 3.2% (n = 80); only 16 procedures (0.6%) were failed. The complication incidence was 19.8% (n = 497), with 789 total complications. Most of the complications were patient-related (90.4%), and the most of them were urticaria (29.1%), occlusion (3.2%), and faulty systems (1.01%), respectively. The use of only fresh frozen plasma as replacement fluid caused a higher complication rate (22.1%, p < 0.01).</p><p><strong>Conclusion: </strong>The number of TPEPs is increasing every day. Hematologic indications for TPE and the use of fresh frozen plasma may increase the risk of complications.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"912-922"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141461504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Life-threatening intracardiac thrombus after plasmapheresis in a child with acquired thrombotic thrombocytopenic purpura. 一名患后天性血栓性血小板减少性紫癜的儿童在接受浆液抽取术后出现危及生命的心内血栓。
Beyza Kılınç, Fatma Hayvacı Canbeyli, Mutlu Uysal Yazıcı, Zühre Kaya
{"title":"Life-threatening intracardiac thrombus after plasmapheresis in a child with acquired thrombotic thrombocytopenic purpura.","authors":"Beyza Kılınç, Fatma Hayvacı Canbeyli, Mutlu Uysal Yazıcı, Zühre Kaya","doi":"10.1111/1744-9987.14210","DOIUrl":"10.1111/1744-9987.14210","url":null,"abstract":"","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"969-970"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142305342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of acute kidney injury with continuous renal replacement therapy and cytokine adsorber (CytoSorb®) in critically ill patients with COVID-19. 用持续肾脏替代疗法和细胞因子吸附剂(CytoSorb®)治疗 COVID-19 重症患者的急性肾损伤。
Eva Jakopin, Maša Knehtl, Nina Vodošek Hojs, Sebastjan Bevc, Nejc Piko, Radovan Hojs, Robert Ekart

Introduction: This retrospective study aimed to evaluate the 30 and 60-day survival of critically ill patients with COVID-19 and AKI.

Methods: Inflammatory and biochemical biomarkers, length of intensive care unit (ICU) stay and mortality at Day 30 and Day 60 after ICU admission were analyzed. A total of 44 patients treated with continuous renal replacement therapy (CRRT) with cytokine adsorber (CA group) were compared to 58 patients treated with CRRT alone (non-CA group).

Results: Patients in CA group were younger, had better preserved kidney function prior to the beginning of CRRT and had higher levels of interleukin-6. There were no statistically significant differences in their comorbidities and in other measured biomarkers between the two groups. The number of patients who died 60 days after ICU admission was statistically significantly higher in non-CA group (p = 0.029).

Conclusion: Treatment with CRRT and cytokine adsorber may have positively influenced 60-day survival in our COVID-19 ICU patients with AKI.

简介这项回顾性研究旨在评估COVID-19和AKI重症患者的30天和60天存活率:分析了炎症和生化生物标志物、重症监护室(ICU)住院时间以及入院后第30天和第60天的死亡率。共有44名患者接受了带有细胞因子吸附剂的持续肾脏替代治疗(CRRT)(CA组),58名患者仅接受了CRRT治疗(非CA组):结果:CA 组患者更年轻,开始 CRRT 前肾功能保存较好,白细胞介素-6 水平较高。两组患者的合并症和其他生物标志物在统计学上没有明显差异。非CA组患者在入住ICU 60天后死亡的人数在统计学上明显更高(P = 0.029):结论:使用 CRRT 和细胞因子吸附剂治疗可能会对我们 COVID-19 ICU 中的 AKI 患者的 60 天存活率产生积极影响。
{"title":"Treatment of acute kidney injury with continuous renal replacement therapy and cytokine adsorber (CytoSorb®) in critically ill patients with COVID-19.","authors":"Eva Jakopin, Maša Knehtl, Nina Vodošek Hojs, Sebastjan Bevc, Nejc Piko, Radovan Hojs, Robert Ekart","doi":"10.1111/1744-9987.14182","DOIUrl":"10.1111/1744-9987.14182","url":null,"abstract":"<p><strong>Introduction: </strong>This retrospective study aimed to evaluate the 30 and 60-day survival of critically ill patients with COVID-19 and AKI.</p><p><strong>Methods: </strong>Inflammatory and biochemical biomarkers, length of intensive care unit (ICU) stay and mortality at Day 30 and Day 60 after ICU admission were analyzed. A total of 44 patients treated with continuous renal replacement therapy (CRRT) with cytokine adsorber (CA group) were compared to 58 patients treated with CRRT alone (non-CA group).</p><p><strong>Results: </strong>Patients in CA group were younger, had better preserved kidney function prior to the beginning of CRRT and had higher levels of interleukin-6. There were no statistically significant differences in their comorbidities and in other measured biomarkers between the two groups. The number of patients who died 60 days after ICU admission was statistically significantly higher in non-CA group (p = 0.029).</p><p><strong>Conclusion: </strong>Treatment with CRRT and cytokine adsorber may have positively influenced 60-day survival in our COVID-19 ICU patients with AKI.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"941-950"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141494724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The relationship between changes in peritoneal membrane solute transfer characteristics and cardiac remodeling in patients with peritoneal dialysis. 腹膜透析患者腹膜溶质转移特性的变化与心脏重塑之间的关系。
Mehmet Ası Oktan, Berfu Korucu, Ayşe Çolak, Yelda Deligöz Bildacı, Caner Çavdar, Serpil Müge Değer

Introduction: We aimed to determine the relationship between the dilatation of the heart chambers and the change in peritoneal membrane solute transfer characteristics (PMTC) in long-term peritoneal dialysis (PD) patients.

Methods: This is a retrospective, single-center study including the follow-up of maintenance PD patients. According to the changes in PMTC from baseline to the last visit, patients were divided into three groups; stable (n = 11), increased (n = 41), and decreased transporters (n = 35).

Results: Left atrium (LA) and Right ventricle (RV) dilatation were more prominent in the PMTC-decreased group compared to PMTC-increased and stable groups (p < 0.001 and p = 0.07, respectively). The Cox regression analysis showed that only decreased PMTC was associated with LA dilatation (HR 2.89 [CI 95%1.54, 5.45] p < 0.01) and RV dilatation (HR 3.01 [CI 95%1.40, 6.21] p < 0.01).

Conclusion: PD can be associated with unfavorable dynamic changes in cardiac structure and functions even at the subclinical level.

简介我们旨在确定长期腹膜透析(PD)患者心腔扩张与腹膜溶质转移特性(PMTC)变化之间的关系:这是一项回顾性单中心研究,包括对维持性腹膜透析患者的随访。根据从基线到最后一次就诊时 PMTC 的变化,将患者分为三组:稳定组(11 人)、转运体增加组(41 人)和转运体减少组(35 人):结果:与 PMTC 增加组和稳定组相比,PMTC 减少组患者的左心房(LA)和右心室(RV)扩张更为显著(P 结论:PD 可与不利于患者的疾病相关:即使在亚临床水平,PD 也可能与心脏结构和功能的不利动态变化有关。
{"title":"The relationship between changes in peritoneal membrane solute transfer characteristics and cardiac remodeling in patients with peritoneal dialysis.","authors":"Mehmet Ası Oktan, Berfu Korucu, Ayşe Çolak, Yelda Deligöz Bildacı, Caner Çavdar, Serpil Müge Değer","doi":"10.1111/1744-9987.14170","DOIUrl":"10.1111/1744-9987.14170","url":null,"abstract":"<p><strong>Introduction: </strong>We aimed to determine the relationship between the dilatation of the heart chambers and the change in peritoneal membrane solute transfer characteristics (PMTC) in long-term peritoneal dialysis (PD) patients.</p><p><strong>Methods: </strong>This is a retrospective, single-center study including the follow-up of maintenance PD patients. According to the changes in PMTC from baseline to the last visit, patients were divided into three groups; stable (n = 11), increased (n = 41), and decreased transporters (n = 35).</p><p><strong>Results: </strong>Left atrium (LA) and Right ventricle (RV) dilatation were more prominent in the PMTC-decreased group compared to PMTC-increased and stable groups (p < 0.001 and p = 0.07, respectively). The Cox regression analysis showed that only decreased PMTC was associated with LA dilatation (HR 2.89 [CI 95%1.54, 5.45] p < 0.01) and RV dilatation (HR 3.01 [CI 95%1.40, 6.21] p < 0.01).</p><p><strong>Conclusion: </strong>PD can be associated with unfavorable dynamic changes in cardiac structure and functions even at the subclinical level.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"871-879"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141262224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determining the effect of arteriovenous fistula care training on the self-care behaviors of hemodialysis patients. 确定动静脉内瘘护理培训对血液透析患者自我护理行为的影响。
Yakup Dilbilir, Mehtap Kavurmaci

Introduction: The aim was to determine the effect of arteriovenous fistula (AVF) care training given to hemodialysis (HD) patients on the self-care behaviors of patients.

Methods: The randomized controlled experimental study was conducted in the HD unit. The study was carried out with a total of 66 patients. Patients in the intervention group were trained using the AVF Care Education Book for 4 weeks. The study data were collected using the scale for evaluating self-care behaviors related to AVF in HD patients (ASBHD-AVF). Shapiro-Wilk and Kolmogorov-Smirnov tests, independent t-tests, and ANOVA were used in the SPSS 25.0 package program.

Results: As a result of the research, it was determined that the average ASBHD-AVF score of the patients in the trained intervention group increased from 54.52 ± 7.41 to 73.77 ± 3.05 (p <0.05). The mean ASBHD-AVF score of the patients in the control group increased from 56.14 ± 4.51 to 58.14 ± 5.93 (p >0.05). When the difference between the two groups was examined, it was determined that the average ASBHD-AVF score of the patients in the intervention group was statistically significantly higher than the control group (p <0.05).

Conclusion: AVF care education given to HD patients improves patients' self-care behaviors. Improved fistula self-care behaviors of patients will contribute to the healthy functioning of the AVF and the effective HD treatment of patients.

导言目的是确定对血液透析(HD)患者进行动静脉内瘘护理培训对患者自我护理行为的影响:方法:在血液透析室进行随机对照实验研究。方法:随机对照实验研究在血液透析室进行,共有 66 名患者参加。干预组患者接受了为期 4 周的 AVF 护理教育手册培训。研究数据采用评估与 HD 患者 AVF 相关的自我护理行为的量表(ASBHD-AVF)进行收集。在 SPSS 25.0 软件包程序中使用了 Shapiro-Wilk 和 Kolmogorov-Smirnov 检验、独立 t 检验和方差分析:研究结果表明,受训干预组患者的 ASBHD-AVF 平均得分从(54.52±7.41)分增至(73.77±3.05)分(P 0.05)。当研究两组之间的差异时,发现干预组患者的 ASBHD-AVF 平均得分在统计学上明显高于对照组(P 结论:干预组患者的 ASBHD-AVF 平均得分从 54.52 ± 7.41 增加到 73.77 ± 3.05(P 0.05):对 HD 患者进行 AVF 护理教育可改善患者的自我护理行为。改善患者的瘘管自我护理行为将有助于 AVF 的健康运行和患者接受有效的 HD 治疗。
{"title":"Determining the effect of arteriovenous fistula care training on the self-care behaviors of hemodialysis patients.","authors":"Yakup Dilbilir, Mehtap Kavurmaci","doi":"10.1111/1744-9987.14174","DOIUrl":"10.1111/1744-9987.14174","url":null,"abstract":"<p><strong>Introduction: </strong>The aim was to determine the effect of arteriovenous fistula (AVF) care training given to hemodialysis (HD) patients on the self-care behaviors of patients.</p><p><strong>Methods: </strong>The randomized controlled experimental study was conducted in the HD unit. The study was carried out with a total of 66 patients. Patients in the intervention group were trained using the AVF Care Education Book for 4 weeks. The study data were collected using the scale for evaluating self-care behaviors related to AVF in HD patients (ASBHD-AVF). Shapiro-Wilk and Kolmogorov-Smirnov tests, independent t-tests, and ANOVA were used in the SPSS 25.0 package program.</p><p><strong>Results: </strong>As a result of the research, it was determined that the average ASBHD-AVF score of the patients in the trained intervention group increased from 54.52 ± 7.41 to 73.77 ± 3.05 (p <0.05). The mean ASBHD-AVF score of the patients in the control group increased from 56.14 ± 4.51 to 58.14 ± 5.93 (p >0.05). When the difference between the two groups was examined, it was determined that the average ASBHD-AVF score of the patients in the intervention group was statistically significantly higher than the control group (p <0.05).</p><p><strong>Conclusion: </strong>AVF care education given to HD patients improves patients' self-care behaviors. Improved fistula self-care behaviors of patients will contribute to the healthy functioning of the AVF and the effective HD treatment of patients.</p>","PeriodicalId":94253,"journal":{"name":"Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy","volume":" ","pages":"893-903"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141319444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1